Abstract
References
- Adelman M, Albelda SM, Gottlieb J, Haponik EF. 1984. Diagnostic utility of pleural fluid eosinophilia. The American J Med, 77(5): 915-920.
- André S, Drowart A, De Bels D. 2005. Lymphocytic pleural effusion associated with valproic acid. European J Inter Med, 16(7): 535.
- Antony VB. 1998. Drug-induced pleural disease. Clinics in chest Med, 19(2): 331-340.
- Bally C, Martin C, Kraoua S, Kanaan R, Lacronique J, Dusser D, Burgel P. 2011. Eosinophilic pleural effusion related to taking valproic acid. Revue de Pneum Clin, 67(6): 363.
- Heidecker J, Kaplan A, Sahn SA. 2006. Pleural fluid and peripheral eosinophilia from hemothorax: Hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax. The American J Med Sci, 332(3): 148-152.
- Huggins JT, Sahn SA. 2004. Drug-induced pleural disease. Clinics in Chest Med, 25(1): 141-153.
- Kalomenidis I, Light RW. 2003. Eosinophilic pleural effusions. Current Opin Pulmon Med, 9(4): 254-260.
- Kaufman J, O'Shaughnessy IM. 1995. Eosinophilic pleural effusion associated with valproic acid administration. Southern Med J, 88(8): 881-882.
- Krenke R, Nasilowski J, Korczynski P, Gorska K, Przybylowski T, Chazan R, Light RW. 2009. Incidence and aetiology of eosinophilic pleural effusion. European Respir J, 34(5): 1111-1117.
- Rubins JB, Rubins HB. 1996. Etiology and prognostic significance of eosinophilic pleural effusions: a prospective study. Chest, 110(5): 1271-1274.
Abstract
Valproic acid is widely used in the treatment of many diseases. It has common side effects such as nausea, vomiting, diarrhea, dizziness, tremor, hair loss, thrombocytopenia. Valproic acid can rarely cause eosinophilic pleuropericardial effusion. Case report; a 31-year-old male patient who had been using valproic acid since childhood due to epilepsy presented with respiratory distress. Eosinophilic pleuropericardial effusion was detected in the examinations performed in the patient with progressive respiratory distress. After excluding other etiological causes, this condition is assumed to be related to valproic acid. Drug changes were made. The end of six months, was observed to be completely cured. Conclusion: This adverse is generally thought to result from drug hypersensitivity reaction. But it is seen that it is an important factor in drug dosage.
References
- Adelman M, Albelda SM, Gottlieb J, Haponik EF. 1984. Diagnostic utility of pleural fluid eosinophilia. The American J Med, 77(5): 915-920.
- André S, Drowart A, De Bels D. 2005. Lymphocytic pleural effusion associated with valproic acid. European J Inter Med, 16(7): 535.
- Antony VB. 1998. Drug-induced pleural disease. Clinics in chest Med, 19(2): 331-340.
- Bally C, Martin C, Kraoua S, Kanaan R, Lacronique J, Dusser D, Burgel P. 2011. Eosinophilic pleural effusion related to taking valproic acid. Revue de Pneum Clin, 67(6): 363.
- Heidecker J, Kaplan A, Sahn SA. 2006. Pleural fluid and peripheral eosinophilia from hemothorax: Hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax. The American J Med Sci, 332(3): 148-152.
- Huggins JT, Sahn SA. 2004. Drug-induced pleural disease. Clinics in Chest Med, 25(1): 141-153.
- Kalomenidis I, Light RW. 2003. Eosinophilic pleural effusions. Current Opin Pulmon Med, 9(4): 254-260.
- Kaufman J, O'Shaughnessy IM. 1995. Eosinophilic pleural effusion associated with valproic acid administration. Southern Med J, 88(8): 881-882.
- Krenke R, Nasilowski J, Korczynski P, Gorska K, Przybylowski T, Chazan R, Light RW. 2009. Incidence and aetiology of eosinophilic pleural effusion. European Respir J, 34(5): 1111-1117.
- Rubins JB, Rubins HB. 1996. Etiology and prognostic significance of eosinophilic pleural effusions: a prospective study. Chest, 110(5): 1271-1274.
Details
| Primary Language | English |
|---|---|
| Subjects | Internal Diseases |
| Journal Section | Case Report |
| Authors | |
| Publication Date | January 1, 2022 |
| Submission Date | April 30, 2021 |
| Acceptance Date | December 1, 2021 |
| Published in Issue | Year 2022 Volume: 5 Issue: 1 |
